IP12: Stone Disease: Epidemiology & Evaluation I
Friday, May 15, 2026 9:30 AM to 11:30 AM · 2 hr. (America/New_York)
147B
Poster and Podium Sessions
Stones
Friday, May 15
IP12-01: More than just size: the search for accurate stone volume assessment
Friday, May 15, 2026 9:30 AM to 11:30 AM
147B
Seyed Amiryaghoub Lavasani · UCI Department of Urology
IP12-02: From Length to True Burden: Making Sense of Linear Stone Measurements
Friday, May 15, 2026 9:30 AM to 11:30 AM
147B
Benedikt Winzer
IP12-03: Multimodal integration of CT-derived 3D morphology, radiomics, and deep learning features for predicting urine culture positivity and clinical stratification in ureteral stone patients
Friday, May 15, 2026 9:30 AM to 11:30 AM
147B
Shunsuke Ikuma
IP12-04: CT-Derived Skeletal Muscle Mass and Visceral Adiposity Metrics Influence 24-hour Urine Lithogenic Parameters in Stone-forming Patients
Friday, May 15, 2026 9:30 AM to 11:30 AM
147B
Reza Lahiji
IP12-05: Artificial Intelligence Derived Body Composition is Associated with 24-hour Urine Markers Using Routine CT Imaging
Friday, May 15, 2026 9:30 AM to 11:30 AM
147B
Reza Lahiji
IP12-06: Artificial intelligence deep learning combined with radiomics in preoperative imaging diagnosis of medullary sponge kidney stones
Friday, May 15, 2026 9:30 AM to 11:30 AM
147B
Yubao Liu · Beijing Tsinghua Changgung Hospital
IP12-07: Nephrocalcinosis – a radiological finding worthy of genetic testing
Friday, May 15, 2026 9:30 AM to 11:30 AM
147B
Wei Jen Chen
IP12-08: Using non-destructive 3D micro-CT imaging to predict relative calcium oxalate and uric acid compositions in kidney stones
Friday, May 15, 2026 9:30 AM to 11:30 AM
147B
Abbas Hammoud
IP12-09: Validation of the Diminished Nephrogram as an Indicator of Renal Obstruction in Patients with Acute Ureteral Stones
Friday, May 15, 2026 9:30 AM to 11:30 AM
147B
Satomi Kiriakedis · OHSU
IP12-10: Very-Low-Dose CT with Automated Assessment: An Ex Vivo Study Quantifying Residual Small Stones
Friday, May 15, 2026 9:30 AM to 11:30 AM
147B
Naoto Tanaka
IP12-11: GLP-1 Receptor Agonists Reduce Kidney Stone Events in Obese Patients: Evidence from a Real-World Cohort
Friday, May 15, 2026 9:30 AM to 11:30 AM
147B
Thomas Syphan · Case Western Reserve University
IP12-12: Distinct urinary microbial profiles in calcium oxalate urolithiasis: A 16S rRNA-based comparative study
Friday, May 15, 2026 9:30 AM to 11:30 AM
147B
Wonku Hwang
IP12-13: Development and Validation of a Predictive Model for Kidney Stone Recurrence: Integrating Gut Multi-Omics and Clinical Profiles
Friday, May 15, 2026 9:30 AM to 11:30 AM
147B
Kai Dang · Beijing Friendship Hospital
IP12-14: Gut Microbiome and Metabolome Signatures in Renal Stone Recurrence: A Multi-Omics Study
Friday, May 15, 2026 9:30 AM to 11:30 AM
147B
Teng Cui
IP12-15: Optimal Preoperative Culture Timing: Within 14-days Associated with Reduced Early Sepsis Risk in Urolithiasis Surgery
Friday, May 15, 2026 9:30 AM to 11:30 AM
147B
Calvin Zhao · New York University School of Medicine
IP12-16: A Novel Nomogram with an External Validation to Stratify Risk of Sepsis in Patients Undergoing Ureteral Stent Placement for Obstructing Stones and Presumed Urinary Tract Infection
Friday, May 15, 2026 9:30 AM to 11:30 AM
147B
Michal Segall · Albert Einstein College of Medicine
IP12-17: Stone Treatment for Patients with Recurrent UTIs and Concurrent Non-obstructing Kidney Stones: Does It Matter?
Friday, May 15, 2026 9:30 AM to 11:30 AM
147B
Amber Herbert · Stanford University Department of Urology
IP12-18: From 28 to 6: External Validation of the WISQOL Short Form in a Large Tertiary Stone Cohort
Friday, May 15, 2026 9:30 AM to 11:30 AM
147B
Yadong Lu
IP12-19: Longitudinal Validation of the WISQOL-Short Form: Equivalent Responsiveness to the Full Instrument in a High-Volume Stone Center
Friday, May 15, 2026 9:30 AM to 11:30 AM
147B
Yadong Lu
IP12-20: Association of Social Determinants of Health with Postoperative Complications and Acute Care Utilization after Stone Surgery: Insights from Epic COSMOS
Friday, May 15, 2026 9:30 AM to 11:30 AM
147B
Jose Salvado · University Hospitals, Cleveland Medical Center
IP12-21: Incidence and Predictors of Opioid Prescriptions 1–2 Years After Ureteroscopy
Friday, May 15, 2026 9:30 AM to 11:30 AM
147B
Matthew Cole
IP12-22: Association Between Low Bone Density, Bisphosphonate Therapy, and Urinary Stone Disease: An International Retrospective Review
Friday, May 15, 2026 9:30 AM to 11:30 AM
147B
Matthew Mullen
IP12-24: Urinary pH Fluctuation Triggers Rapid Growth and Phase Transition of Calcium Phosphate Stones
Friday, May 15, 2026 9:30 AM to 11:30 AM
147B
Mihoko Maruyama · Osaka University
IP12-25: EQUIL Supersaturation: A Practical Web-based Stone Risk Tool
Friday, May 15, 2026 9:30 AM to 11:30 AM
147B
Jonathan Diah ·
IP12-26: 24 hour urine collection: predicting stone formers vs. non-stone formers based on a composite score
Friday, May 15, 2026 9:30 AM to 11:30 AM
147B
Sudarshan Srirangapatanam · UCSF BBCMC
IP12-28: Association Between LHRH Agonist Therapy and Urinary Stone Disease in Men with Prostate Cancer: A Live Database Analysis
Friday, May 15, 2026 9:30 AM to 11:30 AM
147B
Jake Bleau
IP12-29: Androgen-Deprivation Therapy and Nephrolithiasis: Divergent Stone Risk by Prior Stone History in Prostate Cancer
Friday, May 15, 2026 9:30 AM to 11:30 AM
147B
Yi Shiou Tseng
IP12-30: Which neurogenic bladder patients are at higher risk of sepsis after percutaneous nephrolithotomy?
Friday, May 15, 2026 9:30 AM to 11:30 AM
147B
Gustavo Monteiro Perrone de Oliveira · Faculdade de Medicina da Universidade de Sao Paulo, Brazil
